| Bioactivity | Insulin lispro is a recombinant human insulin analogue and is one of three rapid-acting insulin analogues available. Insulin lispro can be used for the research of hyperglycaemia in diabetes mellitus[1]. | |||||||||
| Name | Insulin lispro | |||||||||
| CAS | 133107-64-9 | |||||||||
| Formula | C257H383N65O77S6 | |||||||||
| Molar Mass | 5807.63 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Simpson D, et al. Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs. 2007;67(3):407-34. |
Insulin lispro
CAS: 133107-64-9 F: C257H383N65O77S6 W: 5807.63
Insulin lispro is a recombinant human insulin analogue and is one of three rapid-acting insulin analogues available. Ins
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.